- Home
- / EastWest Bioscience
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
EastWest Bioscience financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
$0
2023-05-08
Market Capitalization
$2.5 M
2023-05-08
Revenue
$1.1 M
FY, 2021
CreditSafe Score
?
Score changed on Jun 08, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| CAD | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 |
|---|---|---|---|---|
| Revenue | 129.0K | 1.4M | 923.0K | 1.1M |
| Cost of goods sold | 105.0K | 901.0K | 694.0K | 480.0K |
| Gross profit | 103.0K | 851.0K | 612.0K | 577.0K |
| Gross profit margin, % | 61.2% | 66.3% | 54.6% | |
| Operating expense total | 651.0K | 3.6M | 1.3M | 1.3M |
| Depreciation and amortization | 103.0K | 620.0K | 127.0K | 149.0K |
| EBITDA | (583.0K) | (2.7M) | (674.0K) | (745.0K) |
| EBITDA margin, % | -196.9% | -73.0% | -70.5% | |
| EBIT | (1.9M) | (3.4M) | (303.0K) | (501.0K) |
| EBIT margin, % | -244.0% | -32.8% | -47.4% | |
| Interest expense | 192.0K | 258.0K | 202.0K | 213.0K |
| Pre tax profit | (3.3M) | (3.6M) | (1.1M) | (1.6M) |
| Net Income | (3.3M) | (3.6M) | (1.1M) | (1.6M) |